
IceCure Medical, an Israeli company developing a minimally invasive medical device for treating tumors, recently announced that it will start offering its technology, called cryoablation, in Israel in upcoming weeks.
The company’s device is an ultrasound imaging-guided probe that injects liquid nitrogen into a tumor and does not require hospitalization, leaves minimal to no scarring, and has a short recovery time. Destroyed tumor cells are then reabsorbed in the body over time.
The treatment, which is approved in the US and the European Union, will be available in Israel to women suffering from fibroadenomas, benign breast tumors usually found in women under 30, and for patients with malignant kidney tumors.
Article excerpts from calcalisttech.com
Dr. Eyal Porat, recently returned from India where he was part of a prestigious group representing Israel in the fields of medicine, culture, sports and culinary arts.
One of the major roles of genetic testing
in today's modern world is to provide a
simple and easy method of diagnosing
genetic diseases in order to save lives.
Maayana Miskin, Arutz Sheva, Israel National News
Eight Israelis were given a second chance at life this week as doctors at Rabin Medical Center's Beilinson Hospital performed several complex transplant operations over just a few days.